Galectin-3 in Critically Ill Patients with Sepsis and/or Trauma: A Good Predictor of Outcome or Not?
By:
References
- 1. Surbatovic M, Vojvodic D, Khan W. Immune response in critically ill patients. Mediators Inflamm 2018; 2018:9524315.
- 2. Diaz-Alvarez L, Ortega E. The many roles of galectin-3, a multifaceted molecule, in innate immune responses against pathogens. Mediators Inflamm 2017; 2017:9247574.
- 3. Vasta GR. Galectins as pattern recognition receptors: structure, function and evolution. Adv Exp Med Biol 2012; 946:21-36.
- 4. Nio-Kobayashi J. Tissue- and cell-specific localization of galectins, beta-galactose-binding animal lectins, and their potential functions in health and disease. Anat Sci Int 2017; 92:25-36.
- 5. Djordjevic D, Pejovic J, Surbatovic M, et al. Prognostic value and daily trend of interleukin-6, neutrophil CD64 expression, C-reactive protein and lipopolysaccharide-binding protein in critically ill patients: reliable predictors of outcome or not? J Med Biochem 2015; 34(4):431-9.
- 6. Surbatovic M, Radakovic S. Tumor necrosis factor-(alpha) levels in severe acute pancreatitis: is there predictive value regarding severity and outcome? J Clin Gastroenterol 2013; 47:637-43.
- 7. Djordjevic D, Rondovic G, Surbatovic M, et al. Neutro-phil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Mean Platelet Volume-to-Platelet Count Ratio as biomarkers in critically ill and injured patients: which ratio to choose to predict outcome and nature of bacteremia? Mediators Inflamm 2018; 2018:3758068.
- 8. Singer M, Deutschman CS, Seymour CW, et al.The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315: 801-810.
- 9. Miller MC, Ippel H, Suylen D, et al. Binding of polysaccharides to human galectin – 3 at a noncanonical site in its carbohydrate recognition domain. Glycobiology 2016; 26:88-99.
- 10. Ippel H, Miller MC, Vertesy S, et al. Intra- and intermolecular interactions of human galectin – 3: assessment by full-assignment-based NMR. Glycobiology 2016; 26:888-903.
- 11. Sato S, Bhaumik P, St-Pierre G, et al. Role of galectin – 3 in the initial control of Leishmania infection. Crit Rev Immunol 2014; 34:147-175.
- 12. Sato S, St-Pierre C, Bhaumik P, et al. Galectins in innate immunity: dual functions of host soluble beta-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs). Immunol Rev 2009; 230:172-187
- 13. Quattroni P, Li Y, Lucchesi D, et al. Galectin-3 binds Neisseria meningitidis and increases interaction with phagocytic cells. Cell Microbiol 2012; 14:1657-1675.
- 14. Chung AW, Sieling PA, Schenk M, et al. Galectin – 3 regulates the innate immune response of human monocytes. J Infect Dis 2013; 207:947-956.
- 15. Foo SS, Reading PC, Jaillon S, et al. Pentraxins and collectins: friend or foe during pathogen invasion? Trends Microbiol 2015; 23:799-811
- 16. Chen HY, Weng IC, Hong MH, et al. Galectins as bacterial sensors in the host innate response. Curr Opin Microbiol 2014; 17:75-81
- 17. Baseras B, Gaida MM, Kahle N, et al. Galectin – 3 inhibits the chemotaxis of human polymorphonuclear neutrophils in vitro. Immunobiology 2012; 217:83-90.
- 18. Wright RD, Souza PR, Flak MB, et al. Galectin – 3 – null mice display defective neutrophil clearance during acute inflammation. J Leukoc Biol 2017; 101:717-726.
- 19. Mishra BB, Li Q, Steichen AL, et al. Galectin-3 functions as an alarmin: pathogenic role for sepsis development in murine respiratory tularemia. PLoS One 2013; 8:e59616.
- 20. Burguillos MA, Svensson M, Schulte T, et al. Microglia-secreted galectin – 3 acts as a Toll-like receptor 4 ligand and contributes to microglial activation. Cell Rep 2015; 10:1626-1638.
- 21. Chen SS, Sun LW, Brickner H, et al. Downregulating galectin – 3 inhibits proinflammatory cytokine production by human monocyte – derived dendritic cells via RNA interference. Cell Immunol 2015; 294:44-53
- 22. ten Oever J, Giamarellos-Bourboulis EJ, van de Veer-donk FL, et al. Circulating galectin-3 in infections and non-infectious inflammatory diseases. Eur J Clin Microbiol Infect Dis 2013; 32:1605-1610.
- 23. Mueller T, Leitner I, Egger M, et al. Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases. Clin Chim Acta 2015; 445:155-160.
- 24. Dieplinger B, Egger M, Leitner I, et al. Interleukin 6, galectin 3, growth differentiation factor 15, and soluble ST2 for mortality prediction in critically ill patients. J Crit Care 2016; 34:38-45.
- 25. Kim H, Hur M, Moon HW, et al. Multi-marker approach using procalcitonin, presepsin, galectin-3, and soluble suppression of tumorigenicity 2 for the prediction of mortality in sepsis. Ann Intensive Care 2017; 7:27
- 26. Coromilas E, Que-Xu EC, Moore D, et al. Dynamics and prognostic role of galectin-3 in patients with advanced heart failure, during left ventricular assist device support and following heart transplantation. BMC Cardiovasc Disord 2016; 16:138.
- 27. Desmedt V, Desmedt S, Delanghe JR, et al. Galectin – 3 in Renal Pathology: More Than Just an Innocent Bystander. Am J Nephrol 2016; 43:305-317.
- 28. Saccon F, Gatto M, Ghirardello A, et al. Role of galectin – 3 in autoimmune and non-autoimmune nephropathies. Autoimmun Rev 2017; 16:34-47.
- 29. Fritsch K, Mernberger M, Nist A, et al. Galectin-3 interacts with components of the nuclear ribonucleoprotein complex. BMC Cancer 2016; 16:502.
- 30. Wang L, Guo XL. Molecular regulation of galectin-3 expression and therapeutic implication in cancer progression. Biomed Pharmacother 2016; 78:165-171.
Language: English
Page range: 21 - 27
Submitted on: Aug 22, 2018
Accepted on: Sep 4, 2018
Published on: May 29, 2021
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2021 Jasna Jevdjic, Maja Surbatovic, Snezana Milosavljevic, Goran Rondovic, Ivan Stanojevic, Stevan Eric, Nenad Zornic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.